Related Experiment Video

Updated: Aug 11, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Biology of HER2 and its importance in breast cancer

Y Yarden1

  • 1Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel. yosef.yarden@weizmann.ac.il

Oncology
|November 6, 2001
PubMed

Insights

Human epidermal growth factor receptor-2 (HER2) overexpression drives breast cancer proliferation. Anti-HER2 antibodies like Herceptin work by targeting HER2 for cellular degradation, reducing oncogenicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Human epidermal growth factor receptor-2 (HER2/erbB-2) is a transmembrane receptor crucial for cell growth and differentiation.
  • HER2 overexpression/amplification is linked to malignancy and poor prognosis in breast cancer.
  • HER2 functions as a networking receptor, mediating signaling that promotes cancer cell proliferation.

Purpose of the Study:

  • To elucidate the biological mechanisms underlying HER2 function in cancer.
  • To understand how HER2-specific antibodies exert their antitumor effects.
  • To highlight the significance of HER2 biology in breast cancer therapeutics.

Main Methods:

  • Review of HER2 receptor dimerization and ligand-binding properties.
  • Analysis of HER2's role in heterodimer formation, particularly with HER3.
  • Investigation into the mechanism of action for anti-HER2 monoclonal antibodies, including Herceptin.

Main Results:

  • HER2 forms potent, long-lived heterodimers with other HER receptors, especially HER3.
  • HER2 overexpression enhances responsiveness to growth factors, promoting oncogenic transformation.
  • Anti-HER2 antibodies facilitate Cbl-dependent endocytosis and degradation of HER2, reducing tumor cell growth.

Conclusions:

  • HER2-containing heterodimers are key drivers of oncogenic transformation in breast cancer.
  • Targeting HER2 for degradation via Cbl-dependent pathways is a critical mechanism for anti-HER2 antibody efficacy.
  • Understanding HER2 biology is essential for developing effective breast cancer therapies.

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...